Pfizer, Starboard
Pfizer taps Vanguard veteran for board amid fight with Starboard
Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as it faces pressure from activist hedge fund Starboard Value.
Pfizer’s stock dips after two former execs say they won’t support Starboard
Activist investor Starboard Value claims the pharma giant’s former CEO and CFO were “threatened” into backing current management.
Activist investor Starboard has informed Pfizer it has taken a stake
Activist investor Starboard Value is looking to shake up pharma giant Pfizer's sagging stock price.
Pfizer fight with Starboard heats up, hedge fund alleges executive pressure
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the U.S. drugmaker to investigate actions by its board, after two former executives backed out of its campaign against the company.
Activist investor claims Pfizer coerced former execs amid power struggle
As the battle over Pfizer’s future continues, former executives said they would no longer support activist investor Starboard Value.
Ex-Pfizer execs ‘threatened’ for supporting plans to shake up company, Starboard says
In a letter to Pfizer’s board, the activist investor claimed former CEO Ian Read and CFO Frank D’Amelio were pressured to abandon a Starboard-led attempt to change the company’s direction.
Benzinga.com1d
Guggenheim's Longstanding Pfizer Ties Tested Amid Starboard Battle
Speculation surrounds the reversal, with Jeff Smith, CEO of Starboard, claiming Pfizer pressured the ex-executives with ...
Pfizer Is Clashing With Its New Activist Investor. Will It Harm The Stock?
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Pfizer Threatened Ex-CEO Over Work With Activist, Starboard Says
Pfizer Inc. company officials threatened legal action against two former top executives who had been working with Starboard ...
Will Pfizer transform in response to Starboard’s activism?
Hedge fund Starboard Value's latest activist campaign targeting Pfizer (NYSE:PFE) has boosted the company's shares in recent ...
After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
https//insights.som.yale.edu3d
What Critics of Pfizer Are Getting Wrong
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...
STAT6d
Pharmalittle: We’re reading about alleged Pfizer threats, industry payments to peer reviewers, and more
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...